TY - JOUR
T1 - Mucociliary Transit Assessment Using Automatic Tracking in Phase Contrast X-Ray Images of Live Mouse Nasal Airways
AU - Jung, Hye Won
AU - Lee, Ivan
AU - Lee, Sang Heon
AU - Morgan, Kaye
AU - Parsons, David
AU - Donnelley, Martin
N1 - Funding Information:
Open Access funding enabled and organized by CAUL and its Member Institutions. Studies were supported by the WCH Foundation, NHMRC Australia, philanthropic donors via the Cure4CF Foundation, and Pharmaxis Ltd. M.D. was supported by a Robinson Research Institute Career Development Fellowship, K.M. by an ARC DECRA during experiments and then an ARC Future Fellowship during writing. Travel was supported by the Australian Synchrotron International Synchrotron Access Program (ISAP). The ISAP is an initiative of the Australian Government being conducted as part of the NCRIS.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/7/2
Y1 - 2022/7/2
N2 - Purpose: The rate of mucociliary transit (MCT) is an indicator of the hydration and health of the airways for cystic fibrosis (CF). To determine the effectiveness of cystic fibrosis respiratory therapies, we have developed a novel method to non-invasively quantify the local rate and patterns of MCT behaviour in vivo by using synchrotron phase contrast X-ray imaging (PCXI) to visualise the MCT motion of micron-sized spherical particles deposited onto the airway surfaces of live mice. Methods: In this study the baseline MCT behaviour was assessed in the nasal airways of CFTR-null and normal mice which were then treated with hypertonic saline (HS) or mannitol. To assess MCT, the particle motion was tracked throughout the synchrotron PCXI sequences using fully-automated custom image analysis software. Results: There was no significant difference in the MCT rate between normal and CFTR-null mice, but the analysis of MCT particle tracking showed that HS may have a longer duration of action in CFTR-null mice than in the normal mice. Conclusion: This study demonstrated that changes in MCT rate in CF and normal mouse nasal airways can be measured using PCXI and customised tracking software and used for assessing the effects of airway rehydrating pharmaceutical treatments.
AB - Purpose: The rate of mucociliary transit (MCT) is an indicator of the hydration and health of the airways for cystic fibrosis (CF). To determine the effectiveness of cystic fibrosis respiratory therapies, we have developed a novel method to non-invasively quantify the local rate and patterns of MCT behaviour in vivo by using synchrotron phase contrast X-ray imaging (PCXI) to visualise the MCT motion of micron-sized spherical particles deposited onto the airway surfaces of live mice. Methods: In this study the baseline MCT behaviour was assessed in the nasal airways of CFTR-null and normal mice which were then treated with hypertonic saline (HS) or mannitol. To assess MCT, the particle motion was tracked throughout the synchrotron PCXI sequences using fully-automated custom image analysis software. Results: There was no significant difference in the MCT rate between normal and CFTR-null mice, but the analysis of MCT particle tracking showed that HS may have a longer duration of action in CFTR-null mice than in the normal mice. Conclusion: This study demonstrated that changes in MCT rate in CF and normal mouse nasal airways can be measured using PCXI and customised tracking software and used for assessing the effects of airway rehydrating pharmaceutical treatments.
KW - Automatic particle tracking
KW - Cystic fibrosis (CF)
KW - Mucociliary transit (MCT) assessment
KW - Synchrotron phase contrast x-ray images
UR - http://www.scopus.com/inward/record.url?scp=85133240680&partnerID=8YFLogxK
U2 - 10.1007/s40846-022-00718-3
DO - 10.1007/s40846-022-00718-3
M3 - Review Article
AN - SCOPUS:85133240680
JO - Journal of Medical and Biological Engineering
JF - Journal of Medical and Biological Engineering
SN - 1609-0985
ER -